News & Updates
Filter by Specialty:
Polypharmacy in IBD interferes with treatment adherence, therapeutic success
Polypharmacy (PP) arises in nearly one in five patients with inflammatory bowel disease (IBD), particularly in older adults and those with comorbidity, according to a study, adding that PP can complicate adherence to treatment and therapeutic success.
Polypharmacy in IBD interferes with treatment adherence, therapeutic success
14 Mar 2022
Record-high rise in alcohol-related hepatitis during pandemic a cause for alarm
Cases of severe alcohol-related hepatitis requiring inpatient management has dramatically increased during the COVID-19 pandemic, particularly in patients aged <40 years and in women, a study has found.
Record-high rise in alcohol-related hepatitis during pandemic a cause for alarm
12 Mar 2022
Whole-exome sequencing enhances diagnosis in young CRC patients
Whole-exome sequencing (WES) can improve diagnosis rates in young colorectal cancer (CRC) patients who show no pathogenic variants in mismatch repair (MMR) genes or in the adenomatous polyposis coli (APC) gene, reports a recent study.
Whole-exome sequencing enhances diagnosis in young CRC patients
09 Mar 2022
Medication risks an acceptable trade-off for cure of IBS symptoms
Patients with irritable bowel syndrome (IBS) are willing to take on significant medication risks in exchange for a permanent cure of their symptoms, a study has found.